e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
COPD: cardiovascular comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relationships between exacerbation symptoms, recovery and ischaemic heart disease in COPD
A. R. C. Patel, G. C. Donaldson, A. J. Mackay, J. J. P. Goldring, S. Karmali, J. A. Wedzicha, J. R. Hurst (United Kingdom)
Source:
Annual Congress 2010 - COPD: cardiovascular comorbidities
Session:
COPD: cardiovascular comorbidities
Session type:
E-Communication Session
Number:
5209
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. R. C. Patel, G. C. Donaldson, A. J. Mackay, J. J. P. Goldring, S. Karmali, J. A. Wedzicha, J. R. Hurst (United Kingdom). Relationships between exacerbation symptoms, recovery and ischaemic heart disease in COPD. Eur Respir J 2010; 36: Suppl. 54, 5209
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Clinical and functional characteristics of patients with acute severe COPD with or without ischemic heart disease
Source: Eur Respir J 2006; 28: Suppl. 50, 162s
Year: 2006
Underlying ischaemic heart disease assessed by cardiac infarction injury score (CIIS) is under-recognised in our patients hospitalised for COPD exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Mechanisms of exacerbation of respiratory symptoms in patients with CHF
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Physical activity after discharge following chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF) exacerbations
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007
Severity assessment in acute exacerbations of COPD
Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know?
Year: 2005
Generalized muscle dysfunction in COPD and chronic heart failure independent of disease severity
Source: Eur Respir J 2001; 18: Suppl. 33, 183s
Year: 2001
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Heart arrhythmias in patients with chronic obstructive bronchitis and ischemic heart disease
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004
Features of clinical cours of chronic obstructive pulmonary disease and ischemic heart disease in case of comorbidity
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Time to move from prognostication to diagnosis and treatment of heart disease in acute exacerbation of COPD
Source: Eur Respir J, 49 (6) 1700912; 10.1183/13993003.00912-2017
Year: 2017
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Active smoking negatively affects recovery of patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions
Year: 2011
Exercise heart rate recovery in chronic obstructive pulmonary disease patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
COPD and CHF
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013
Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept